Marketing-authorisation holder · United States
Three Rivers Pharmaceuticals LLC
3 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
3 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| AMPHOTEC 100 MG100 mg / vial · Powder For Suspension | Amphotericin b | Canada | Cancelled | 2004 |
| AMPHOTEC 50 MG50 mg / vial · Powder For Suspension | Amphotericin b | Canada | Cancelled | 2007 |
| INFERGEN0.03 mg / ml · Solution | Interferon alfacon-1 | Canada | Cancelled | 1999 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 3 | 0 | 3 | CompaniesAll medicines |
Therapeutic areas
The ATC groups most of its medicines belong to, largest first.
- Antimycotics for systemic useAnti-infectives for systemic use · ATC J02A